Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical <i>Klebsiella pneumoniae</i> ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions. [PDF]
Fu Y +7 more
europepmc +1 more source
Imipenem/Relebactam Plus Aztreonam: First Reported Use in MDR <i>Klebsiella pneumoniae</i> Sternal Infection Complicated by Bacteremia. [PDF]
Pipitò L +8 more
europepmc +1 more source
Can we escape from top-priority ESKAPE pathogens? [PDF]
Zeng L, Feng Y, Wang M.
europepmc +1 more source
Targeting carbapenem-resistant and hypervirulent Klebsiella pneumoniae: in vitro evaluation of cefepime/zidebactam, aztreonam/avibactam, imipenem/relebactam, and meropenem/vaborbactam. [PDF]
Li Y, Li Y, Jia X, Mao H, Li D, Zhang J.
europepmc +1 more source
Guideline for antimicrobial treatment of multidrug-resistant Gram-negative infections: practice recommendations of the Brazilian Society of Infectious Diseases. [PDF]
Zavascki AP +6 more
europepmc +1 more source
Description of a chromosomal <i>fosA6</i> tandem multicopy fragment and its <i>in vivo</i> evolution in consecutive KPC-producing <i>Klebsiella pneumoniae</i> clinical isolates. [PDF]
Mateo-Vargas MA +4 more
europepmc +1 more source
Nacubactam: a review on mechanistic insights and therapeutic promise for combating β-lactam resistance among multidrug-resistant Gram-negative pathogens. [PDF]
Kumar D +4 more
europepmc +1 more source
Emergence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae with Penicillin-Binding Protein 3 Insertions, Taiwan, 2021. [PDF]
Long T +6 more
europepmc +1 more source
Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]
Candel FJ, Matesanz M.
europepmc +1 more source

